A detailed history of Clarity Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clarity Wealth Advisors, LLC holds 30,406 shares of ABBV stock, worth $5.47 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
30,406
Previous 29,079 4.56%
Holding current value
$5.47 Million
Previous $4.99 Million 20.39%
% of portfolio
1.76%
Previous 1.62%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $217,415 - $264,510
1,327 Added 4.56%
30,406 $6 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $168,256 - $196,486
-1,087 Reduced 3.6%
29,079 $4.99 Million
Q1 2024

Apr 17, 2024

BUY
$159.82 - $182.1 $56,736 - $64,645
355 Added 1.19%
30,166 $5.49 Million
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $107,878 - $121,496
784 Added 2.7%
29,811 $4.62 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $130,383 - $150,938
976 Added 3.48%
29,027 $4.33 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $106,273 - $132,249
802 Added 2.94%
28,051 $3.78 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $89,224 - $102,755
617 Added 2.32%
27,249 $4.34 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $35,545 - $42,628
-257 Reduced 0.96%
26,632 $4.31 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $44,691 - $51,258
333 Added 1.25%
26,889 $3.61 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $91,104 - $115,823
662 Added 2.56%
26,556 $4.07 Million
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $22,832 - $28,328
173 Added 0.67%
25,894 $4.2 Million
Q4 2021

Jan 25, 2022

BUY
$107.43 - $135.93 $104,636 - $132,395
974 Added 3.94%
25,721 $3.48 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $138,958 - $157,738
1,306 Added 5.57%
24,747 $2.67 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $165,074 - $183,902
1,569 Added 7.17%
23,441 $2.64 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $61,482 - $67,684
601 Added 2.83%
21,872 $2.37 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $51,594 - $69,657
641 Added 3.11%
21,271 $2.28 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $21,219 - $24,905
247 Added 1.21%
20,630 $1.81 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $39,252 - $52,526
535 Added 2.7%
20,383 $2 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $9,610 - $14,570
149 Added 0.76%
19,848 $1.51 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $1.42 Million - $1.78 Million
19,699 New
19,699 $1.74 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clarity Wealth Advisors, LLC Portfolio

Follow Clarity Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarity Wealth Advisors, LLC with notifications on news.